Literature DB >> 32831960

Tau Imaging: New Era of Neuroimaging for Alzheimer's Disease.

Jae Seung Kim1.   

Abstract

Entities:  

Year:  2020        PMID: 32831960      PMCID: PMC7429640          DOI: 10.1007/s13139-020-00657-4

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


× No keyword cloud information.
  16 in total

1.  [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.

Authors:  Marta Marquié; Michael Siao Tick Chong; Alejandro Antón-Fernández; Eline E Verwer; Nil Sáez-Calveras; Avery C Meltzer; Prianca Ramanan; Ana C Amaral; Jose Gonzalez; Marc D Normandin; Matthew P Frosch; Teresa Gómez-Isla
Journal:  Acta Neuropathol       Date:  2017-06-13       Impact factor: 17.088

2.  [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.

Authors:  Chun-Fang Xia; Janna Arteaga; Gang Chen; Umesh Gangadharmath; Luis F Gomez; Dhanalakshmi Kasi; Chung Lam; Qianwa Liang; Changhui Liu; Vani P Mocharla; Fanrong Mu; Anjana Sinha; Helen Su; A Katrin Szardenings; Joseph C Walsh; Eric Wang; Chul Yu; Wei Zhang; Tieming Zhao; Hartmuth C Kolb
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

3.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Authors:  Rik Ossenkoppele; Daniel R Schonhaut; Michael Schöll; Samuel N Lockhart; Nagehan Ayakta; Suzanne L Baker; James P O'Neil; Mustafa Janabi; Andreas Lazaris; Averill Cantwell; Jacob Vogel; Miguel Santos; Zachary A Miller; Brianne M Bettcher; Keith A Vossel; Joel H Kramer; Maria L Gorno-Tempini; Bruce L Miller; William J Jagust; Gil D Rabinovici
Journal:  Brain       Date:  2016-03-08       Impact factor: 13.501

4.  Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.

Authors:  Marta Marquié; Marc D Normandin; Avery C Meltzer; Michael Siao Tick Chong; Nicolas V Andrea; Alejandro Antón-Fernández; William E Klunk; Chester A Mathis; Milos D Ikonomovic; Manik Debnath; Elizabeth A Bien; Charles R Vanderburg; Isabel Costantino; Sara Makaretz; Sarah L DeVos; Derek H Oakley; Stephen N Gomperts; John H Growdon; Kimiko Domoto-Reilly; Diane Lucente; Bradford C Dickerson; Matthew P Frosch; Bradley T Hyman; Keith A Johnson; Teresa Gómez-Isla
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

5.  18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease.

Authors:  Ilya M Nasrallah; Yin Jie Chen; Meng-Kang Hsieh; Jeffrey S Phillips; Kylie Ternes; Grace E Stockbower; Yvette Sheline; Corey T McMillan; Murray Grossman; David A Wolk
Journal:  J Nucl Med       Date:  2017-07-26       Impact factor: 10.057

Review 6.  Tau imaging: early progress and future directions.

Authors:  Victor L Villemagne; Michelle T Fodero-Tavoletti; Colin L Masters; Christopher C Rowe
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.

Authors:  Brian A Gordon; Karl Friedrichsen; Matthew Brier; Tyler Blazey; Yi Su; Jon Christensen; Patricia Aldea; Jonathan McConathy; David M Holtzman; Nigel J Cairns; John C Morris; Anne M Fagan; Beau M Ances; Tammie L S Benzinger
Journal:  Brain       Date:  2016-06-10       Impact factor: 13.501

9.  Correlation of Early-Phase F-18 Florapronal PET with F-18 FDG PET in Alzheimer's Disease and Normal Brain.

Authors:  Jieun Jeong; Young Jin Jeong; Kyung Won Park; Do-Young Kang
Journal:  Nucl Med Mol Imaging       Date:  2019-09-11

10.  Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.

Authors:  Michael J Pontecorvo; Michael D Devous; Michael Navitsky; Ming Lu; Stephen Salloway; Frederick W Schaerf; Danna Jennings; Anupa K Arora; Anne McGeehan; Nathaniel C Lim; Hui Xiong; Abhinay D Joshi; Andrew Siderowf; Mark A Mintun
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

View more
  3 in total

1.  Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.

Authors:  Elisa Colato; Konstantinos Chiotis; Daniel Ferreira; Mariam S Mazrina; Laetitia Lemoine; Rosaleena Mohanty; Eric Westman; Agneta Nordberg; Elena Rodriguez-Vieitez
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

2.  Volumetric and structural connectivity abnormalities co-localise in TLE.

Authors:  Jonathan J Horsley; Gabrielle M Schroeder; Rhys H Thomas; Jane de Tisi; Sjoerd B Vos; Gavin P Winston; John S Duncan; Yujiang Wang; Peter N Taylor
Journal:  Neuroimage Clin       Date:  2022-07-09       Impact factor: 4.891

3.  Alzheimer's Disease Diagnostics Must Be Globally Accessible.

Authors:  Nicholas Clute-Reinig; Suman Jayadev; Kristoffer Rhoads; Anne-Laure Le Ny
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.